Small Miscellaneous

Novartis India Ltd.

NOVARTIND

Market Cap
₹3,602 Cr.
P/E
38.66

Novartis India Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
3,602 Cr
PE
PE
38.66
Prom Holding
Prom Holding
70.68 %
ROE (%)
ROE (%)
12.85
ROCE (%)
ROCE (%)
8.85
Div Yield (%)
Div Yield (%)
-
Sales
Sales
354 Cr
OPM (%)
OPM (%)
26.56 %
Debt to Equity
Debt to Equity
-
Institutions
Institutions
0.69 %
Individual < 2 lac
Individual < 2 lac
19.96 %
No. of Shareholders
No. of Shareholders
38,116
View more
Edit Ratio's

About

Novartis India Limited is a pharmaceutical company with operations in Pharmaceuticals, Generic… Read more
Low
750
52W Range
High
1588
  • Novartis India
  • Panacea Biotec
  • Gufic Biosciences
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

1.80 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0.06 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
0.09 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
0.14 %
(as of May 19)
Historic
Blood Related - Market Share
0.72 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
0.03 %
(as of Nov 21)
Historic
Dermatology - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • Domestic Sales Growth - YoY (%)
      Source

    Peer Comparison

    Brands

    Voveran

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Bharat Dynamics Ltd.
    • Navin Fluorine International Ltd.
    • Piramal Enterprises Ltd. - (Amalgamated)
    • Neuland Laboratories Ltd.
    • Aarti Industries Ltd.

    FAQs on Novartis India Ltd. Business

    Novartis India Limited operates in pharmaceuticals, generics, over the counter (OTC), and animal health segments. It provides prescription medicines, retail generic products, and products for cattle and poultry markets.

    Novartis India major competitors are Panacea Biotec, Gufic Biosciences, Unichem Laboratories, Guj. Themis Biosyn, Kwality Pharma, Orchid Pharma, Beta Drugs.
    Market Cap of Novartis India is ₹3,627 Crs.
    While the median market cap of its peers are ₹3,366 Crs.

    Novartis India seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation Dec
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material